306 related articles for article (PubMed ID: 23049798)
1. ShRNA-targeted COMMD7 suppresses hepatocellular carcinoma growth.
Zheng L; Liang P; Li J; Huang XB; Liu SC; Zhao HZ; Han KQ; Wang Z
PLoS One; 2012; 7(9):e45412. PubMed ID: 23049798
[TBL] [Abstract][Full Text] [Related]
2. COMMD7 is correlated with a novel NF-κB positive feedback loop in hepatocellular carcinoma.
Zheng L; Deng CL; Wang L; Huang XB; You N; Tang YC; Wu K; Liang P; Mi N; Li J
Oncotarget; 2016 May; 7(22):32774-84. PubMed ID: 27129158
[TBL] [Abstract][Full Text] [Related]
3. Eukaryotic elongation factor-1α 2 knockdown inhibits hepatocarcinogenesis by suppressing PI3K/Akt/NF-κB signaling.
Qiu FN; Huang Y; Chen DY; Li F; Wu YA; Wu WB; Huang XL
World J Gastroenterol; 2016 Apr; 22(16):4226-37. PubMed ID: 27122673
[TBL] [Abstract][Full Text] [Related]
4. EYA4 inhibits hepatocellular carcinoma growth and invasion by suppressing NF-κB-dependent RAP1 transactivation.
Mo SJ; Hou X; Hao XY; Cai JP; Liu X; Chen W; Chen D; Yin XY
Cancer Commun (Lond); 2018 Apr; 38(1):9. PubMed ID: 29764501
[TBL] [Abstract][Full Text] [Related]
5. [Inhibition of SMYD3 gene expression by RNA interference induces apoptosis in human hepatocellular carcinoma cell line HepG2].
Xu JY; Chen LB; Xu JY; Yang Z; Wei HY; Xu RH
Ai Zheng; 2006 May; 25(5):526-32. PubMed ID: 16687068
[TBL] [Abstract][Full Text] [Related]
6. Tumor necrosis factor α-induced protein 1 as a novel tumor suppressor through selective downregulation of CSNK2B blocks nuclear factor-κB activation in hepatocellular carcinoma.
Xiao Y; Huang S; Qiu F; Ding X; Sun Y; Wei C; Hu X; Wei K; Long S; Xie L; Xun Y; Chen W; Zhang Z; Liu N; Xiang S
EBioMedicine; 2020 Jan; 51():102603. PubMed ID: 31901862
[TBL] [Abstract][Full Text] [Related]
7. Tripartite motif-containing 3 (TRIM3) inhibits tumor growth and metastasis of liver cancer.
Huang XQ; Zhang XF; Xia JH; Chao J; Pan QZ; Zhao JJ; Zhou ZQ; Chen CL; Tang Y; Weng DS; Zhang JH; Xia JC
Chin J Cancer; 2017 Sep; 36(1):77. PubMed ID: 28950898
[TBL] [Abstract][Full Text] [Related]
8. Effect of PAK1 gene silencing on proliferation and apoptosis in hepatocellular carcinoma cell lines MHCC97-H and HepG2 and cells in xenograft tumor.
Zhang ZL; Liu GC; Peng L; Zhang C; Jia YM; Yang WH; Mao L
Gene Ther; 2018 Jul; 25(4):284-296. PubMed ID: 29802374
[TBL] [Abstract][Full Text] [Related]
9. MKL1 regulates hepatocellular carcinoma cell proliferation, migration and apoptosis via the COMPASS complex and NF-κB signaling.
Liu Z; Sun J; Li C; Xu L; Liu J
BMC Cancer; 2021 Nov; 21(1):1184. PubMed ID: 34742274
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of RIP140 suppresses the malignant potential of hepatocellular carcinoma by inhibiting NF‑κB‑mediated alternative polarization of macrophages.
Hu YC; Yi ZJ; Zhou Y; Li PZ; Liu ZJ; Duan SG; Gong JP
Oncol Rep; 2017 May; 37(5):2971-2979. PubMed ID: 28393222
[TBL] [Abstract][Full Text] [Related]
11. Regulation of HSP27 on NF-kappaB pathway activation may be involved in metastatic hepatocellular carcinoma cells apoptosis.
Guo K; Kang NX; Li Y; Sun L; Gan L; Cui FJ; Gao MD; Liu KY
BMC Cancer; 2009 Mar; 9():100. PubMed ID: 19331697
[TBL] [Abstract][Full Text] [Related]
12. Silencing of TRAF5 enhances necroptosis in hepatocellular carcinoma by inhibiting LTBR-mediated NF-κB signaling.
Wu G; Wu F; Zhou YQ; Lu W; Hu FL; Fan X
PeerJ; 2023; 11():e15551. PubMed ID: 37366426
[TBL] [Abstract][Full Text] [Related]
13. Autotaxin expression and its connection with the TNF-alpha-NF-kappaB axis in human hepatocellular carcinoma.
Wu JM; Xu Y; Skill NJ; Sheng H; Zhao Z; Yu M; Saxena R; Maluccio MA
Mol Cancer; 2010 Mar; 9():71. PubMed ID: 20356387
[TBL] [Abstract][Full Text] [Related]
14. Fluoxetine Induces Apoptosis through Extrinsic/Intrinsic Pathways and Inhibits ERK/NF-κB-Modulated Anti-Apoptotic and Invasive Potential in Hepatocellular Carcinoma Cells In Vitro.
Chen WT; Hsu FT; Liu YC; Chen CH; Hsu LC; Lin SS
Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30754643
[TBL] [Abstract][Full Text] [Related]
15. URG4/URGCP enhances the angiogenic capacity of human hepatocellular carcinoma cells in vitro via activation of the NF-κB signaling pathway.
Xing S; Zhang B; Hua R; Tai WC; Zeng Z; Xie B; Huang C; Xue J; Xiong S; Yang J; Liu S; Li H
BMC Cancer; 2015 May; 15():368. PubMed ID: 25947641
[TBL] [Abstract][Full Text] [Related]
16. COMMD7 promotes hepatocellular carcinoma through regulating CXCL10.
You N; Li J; Huang X; Wu K; Tang Y; Wang L; Li H; Mi N; Zheng L
Biomed Pharmacother; 2017 Apr; 88():653-657. PubMed ID: 28142122
[TBL] [Abstract][Full Text] [Related]
17. S100A4 regulates migration and invasion in hepatocellular carcinoma HepG2 cells via NF-κB-dependent MMP-9 signal.
Zhang J; Zhang DL; Jiao XL; Dong Q
Eur Rev Med Pharmacol Sci; 2013 Sep; 17(17):2372-82. PubMed ID: 24065232
[TBL] [Abstract][Full Text] [Related]
18. Secalonic Acid-F, a Novel Mycotoxin, Represses the Progression of Hepatocellular Carcinoma via MARCH1 Regulation of the PI3K/AKT/β-catenin Signaling Pathway.
Xie L; Li M; Liu D; Wang X; Wang P; Dai H; Yang W; Liu W; Hu X; Zhao M
Molecules; 2019 Jan; 24(3):. PubMed ID: 30678274
[TBL] [Abstract][Full Text] [Related]
19. COMMD7 activates CXCL10 production by regulating NF-κB and the production of reactive oxygen species.
You N; Li J; Huang X; Wu K; Tang Y; Wang L; Li H; Mi N; Zheng L
Mol Med Rep; 2018 May; 17(5):6784-6788. PubMed ID: 29532873
[TBL] [Abstract][Full Text] [Related]
20. Anticancer activity of dietary xanthone α-mangostin against hepatocellular carcinoma by inhibition of STAT3 signaling via stabilization of SHP1.
Zhang H; Tan YP; Zhao L; Wang L; Fu NJ; Zheng SP; Shen XF
Cell Death Dis; 2020 Jan; 11(1):63. PubMed ID: 31980595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]